Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has been granted a new US patent covering its experimental drug certepetide ...
Opposition to data centres in Alberta and Saskatchewan, where projects are underway or proposed, stands at 64 per cent and 70 per cent, respectively, but the greatest level of opposition was 72 per ...
Canada's economy stunned widespread expectations to post a massive job loss in September and the unemployment rate edged up, ...
Apple has long been rumoured to be working on touchscreen laptops – but its executives have pointed to problems with them in ...
Japan's government issued a warning Friday for increased vigilance against cyberattacks, which are rising in number and ...
US tech futures rebounded on Friday, a day after a report that OpenAI’s annualised revenue was $20 billion (€17.8bn) below ...
GoBlinkly, a done-for-you Answer Engine Optimization (AEO) provider for established B2B SaaS companies, announced its 90-Day Promise: if a client is not cited on ChatGPT for at least three ...
A lawsuit by chipmaker Qualcomm against chip technology supplier Arm Holdings will head on Friday to a jury charged with ...
EU countries struck a deal on Friday to give the EU’s financial markets watchdog more powers, aiming to make cross-border ...
Today is World Egg Day, a global celebration of nutritious, versatile eggs and the dedicated farmers who produce them. To ...
OpenAI said on Friday that it fired three safety researchers for a “breach of trust," defending the dismissals after the trio ...
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) reported a wider annual operating loss of £ 17.4 million and expects to start its Phase 3 melanoma vaccine trial in the fourth quarter of 2026. Eco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results